
| Pair Name | Paeoniflorin, Talatizidine | ||
| Phytochemical Name | Paeoniflorin (PubChem CID: 442534 ) | ||
| Anticancer drug Name | Talatizidine (PubChem CID: / ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Paeoniflorin, Talatizidine | |||
| Disease Info | [ICD-11: FA20] | Rheumatoid arthritis | Investigative | |
| Biological Phenomena | Induction-->Adipogenesis and lipogenesis | |||
| Gene Regulation | Up-regulation | Expression | PPARG | hsa5468 |
| Up-regulation | Expression | ALOX15B | hsa247 | |
| Down-regulation | Expression | JUN | hsa3725 | |
| Up-regulation | Expression | MMP13 | hsa4322 | |
| Down-regulation | Expression | TGFB1 | hsa7040 | |
| In Vivo Model | Male Lewis rats were injected intradermally at the base of the tail with 10 mg/mL M tuberculosis H37 Ra suspended in liquid paraffin. | |||
| Result | This study identified PAE and TLT as the main BACs of WTD in alleviating the severity of RA, and also developed a novel combination of PAE and TLT as a promising candidate drug for RA therapy. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis. Pharmacol Res. 2020 Mar;153:104658. doi: 10.1016/j.phrs.2020.104658. | Click |